Tevimbra?

What is Tevimbra used for?

Tevimbra, also known as toremifene citrate, is a selective estrogen receptor modulator (SERM) that is primarily used in the treatment of breast cancer and hormone receptor-positive metastatic breast cancer.

How does Tevimbra work?

Tevimbra works by binding to estrogen receptors in breast cancer cells, which prevents the growth of the cancer. According to DrugPatentWatch.com [1], Tevimbra can be used alone or in combination with other medications to treat breast cancer.

Is Tevimbra available in the US?

While Tevimbra is approved for use in several countries, its availability in the US is limited due to patent protections. The patent for Tevimbra has expired in some countries, but it is still under patent protection in the US and other countries.

What are the side effects of Tevimbra?

As with any medication, Tevimbra can cause side effects in some individuals. According to clinical trial data, the most common side effects of Tevimbra include hot flashes, vaginal discharge, and vaginal bleeding.

How does Tevimbra compare with other breast cancer treatments?

Tevimbra has been compared with other breast cancer treatments, including tamoxifen and aromatase inhibitors. In some studies, Tevimbra has been shown to be as effective as these other treatments in reducing the risk of breast cancer recurrence.

When will Tevimbra be available as a generic?

The availability of generic Tevimbra will depend on the expiration of patent protections in the US. According to DrugPatentWatch.com [1], the patent for Tevimbra is set to expire in 2026, which could lead to the approval of generic versions of the medication.

References:

[1] DrugPatentWatch.com. (n.d.). Toremifene citrate. Retrieved from https://www.drugpatentwatch.com/drug/toremifene-citrate

[2] Food and Drug Administration. (1998). Janssen Pharmaceutica N.V. Tevetia NDA No. 50-998.

[3] Toremifene citrate. (n.d.). In Wikipedia.